Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$30.61
-6.35%
Mkt Cap $3.40B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
Implied Upside
+6.7%
Consensus $32.67 vs current $30.61
NASDAQ·Healthcare·Biotechnology
$30.61
-6.35%
Mkt Cap $3.40B
Buy
10
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
+6.7%
Consensus $32.67 vs current $30.61